Literature DB >> 1873719

Realistic expectations for the patient with intermittent claudication.

D S O'Riordain1, J A O'Donnell.   

Abstract

To determine the natural history of intermittent claudication 112 patients were followed for a minimum of 5 years and a median period of 82 months. Thirty-seven patients (33 per cent) died during the study period. Myocardial infarction (44 per cent) and cerebrovascular disease (28 per cent) were the most common causes of death. Overall mortality rate was 8, 23 and 40 per cent, at 2, 5 and 8 years respectively. Initial ankle-brachial pressure index (ABPI) correlated with subsequent death. With an initial ABPI less than 0.5 death occurred in 20, 50 and 69 per cent at 2, 5 and 7 years respectively, compared with 5, 16 and 24 per cent respectively for those with an initial ABPI greater than or equal to 0.5 (P less than 0.0001). Of the survivors only 21 per cent had worsening claudication and 13 per cent progressed to critical ischaemia. Arterial bypass for limb salvage was required in eight patients and four limbs were lost during the study period. ABPI identifies a subgroup of claudicants with an extremely high risk of death from coronary and/or cerebral pathology. In this subgroup an aggressive approach to the correction of atherosclerotic risk factors, rather than emphasis on the peripheral vascular problem alone, may improve survival.

Entities:  

Mesh:

Year:  1991        PMID: 1873719     DOI: 10.1002/bjs.1800780728

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

1.  Avoiding amputation.

Authors:  J Collin
Journal:  BMJ       Date:  1992-04-04

2.  Long term results of polytetrafluoroethylene in above knee femoropopliteal bypass for critical ischaemia.

Authors:  E G Kavanagh; D S O'Riordain; D J Buckley; J A O'Donnell
Journal:  Ir J Med Sci       Date:  1998 Oct-Dec       Impact factor: 1.568

Review 3.  The prognosis of non-critical limb ischaemia: a systematic review of population-based evidence.

Authors:  J D Hooi; H E Stoffers; J A Knottnerus; J W van Ree
Journal:  Br J Gen Pract       Date:  1999-01       Impact factor: 5.386

4.  Antiangiogenic VEGF165b Regulates Macrophage Polarization via S100A8/S100A9 in Peripheral Artery Disease.

Authors:  Vijay Chaitanya Ganta; Min Choi; Charles R Farber; Brian H Annex
Journal:  Circulation       Date:  2019-01-08       Impact factor: 29.690

5.  Intermittent claudication: pharmacoeconomic and quality-of-life aspects of treatment.

Authors:  Gregorio Brevetti; Roberta Annecchini; Roxanna Bucur
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

6.  Angina pectoris is a stronger indicator of diffuse vascular atherosclerosis than intermittent claudication: Framingham study.

Authors:  W B Kannel; J C Evans; S Piper; J M Murabito
Journal:  J Clin Epidemiol       Date:  2008-05-20       Impact factor: 6.437

7.  Decrease in circulating dendritic cell precursors in patients with peripheral artery disease.

Authors:  Daniel Kretzschmar; Ilonka Rohm; Sebastian Schäller; Stefan Betge; Rudin Pistulli; Yevgeniya Atiskova; Hans-R Figulla; Atilla Yilmaz
Journal:  Mediators Inflamm       Date:  2015-04-15       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.